CN109022382A - Suspend the method for cultivating insect cell preparation and reorganization TPO albumen - Google Patents

Suspend the method for cultivating insect cell preparation and reorganization TPO albumen Download PDF

Info

Publication number
CN109022382A
CN109022382A CN201811031155.6A CN201811031155A CN109022382A CN 109022382 A CN109022382 A CN 109022382A CN 201811031155 A CN201811031155 A CN 201811031155A CN 109022382 A CN109022382 A CN 109022382A
Authority
CN
China
Prior art keywords
cell
culture
virus liquid
supernatant
reorganization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811031155.6A
Other languages
Chinese (zh)
Inventor
孙静静
陈超
赵巧辉
李桂林
付光宇
吴学炜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Immuno Biotech Co Ltd
Original Assignee
Zhengzhou Immuno Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Immuno Biotech Co Ltd filed Critical Zhengzhou Immuno Biotech Co Ltd
Priority to CN201811031155.6A priority Critical patent/CN109022382A/en
Publication of CN109022382A publication Critical patent/CN109022382A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0065Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14041Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of methods of culture insect cell preparation and reorganization TPO albumen that suspends, and first transfect into logarithmic phase insect cell recombinant baculovirus, supernatant is taken after 96h, harvest P0 for recombinant baculovirus liquid;Primary recombinant baculovirus cell secondary culture, triangular flask is accessed with the inoculum concentration for passing on inoculating cell density >=3-5 × 10^5,2-3 × 10^6 are grown to cell density, secondary culture again, when density is up to 2 × 10^6cells/mL, it is that 0.1-0.5 connect malicious P0 for virus liquid with MOI, harvests cell culture supernatant, it is virus liquid P1 generation after centrifugal treating, masking foil wraps up 4 DEG C and is kept in dark place;Above method is repeated, P2 is made for virus liquid;Continue to pass on, when density reaches 2 × 10^6cells/mL, be that 1-5 connect malicious P2 for virus liquid with MOI, cell culture supernatant is harvested after 3-5 days, be virus liquid P3 generation after centrifugal treating, after bioactivity, obtains recombinating TPO albumen.The antigentic specificity of the method for the present invention preparation is good, and high sensitivity and potency height can greatly improve sensitivity, accuracy and the stability of kit.

Description

Suspend the method for cultivating insect cell preparation and reorganization TPO albumen
Technical field
The present invention relates to Measurements for Biotechnique, cultivate insect cell preparation and reorganization TPO albumen more particularly, to a kind of suspension Method.
Background technique
Baculoviral is the carrier system for being widely used in high efficient expression foreign protein in recent years, the genome of baculoviral For single closed hoop double chain DNA molecule, size is 80~160 kb, and genome in insect cell endoreduplication and can turn Record.It is assembled in after DNA replication dna in the nucleocapsid of baculoviral, the latter has biggish flexibility, can accommodate larger segment Exogenous DNA insertion, therefore be the ideal carrier for expressing large fragment DNA.Carrier is done with baculoviral, it can high efficient expression external source base Up to the present cause has the several hundred genes including animals and plants, virus, bacterium, fungi and obtains in insect cell or larva body To high efficient expression.This expression system be mainly characterized by obtain it is a large amount of antigenicity, immunogenicity it is preferable, with natural egg White intimate soluble recombinant protein.This feature is better than bacterium, yeast and mammalian cell expression system.
After recombinate shape virus infection insect cell, the transcription post-processing of many eukaryocytes can be carried out to foreign protein Effect, including glycosylation, phosphorylation, acylation, correct signal peptide cleavage, proteolysis and folding appropriate effect, and And recombinant protein can also be assembled and be positioned on the same organelle of native protein, moreover it is possible to carry out oligomerization assembly appropriate.Cause This is the ideal carrier for the protein that expression has bioactivity.
Thyroid peroxidase (thyroid peroxidase, TPO) is the important enzyme for being catalyzed thyroid hormone.TPO It is synthesized by thyroid follicular cells, it is by 10% color being saccharified that the molecular weight that 933 amino acid residues form is 103kD Plain sample protein.TPO is the key enzyme for being catalyzed thyroid hormone synthesis, it takes part in TG(thyroglobulin) tyrosine residue Iodate and iodotyrosine coupled action, generation with autoimmune thyroid disease, development are closely related.TPOAb (thyroid peroxidase antibody) can cause thyroid follicle to damage as the major autoantibody of autoimmune thyroid disease Wound, leads to hypothyroidism.Hyperthyroidism is a kind of common autoimmune disease, TPOAb for hyperthyroidism pathogenesis, Diagnoses and treatment and Index for diagnosis are of great importance.
It recombinates TPO albumen to use in thyroid peroxidase antibody detection kit as antigen, it is desirable that biology is living Property high, high sensitivity.Recombination TPO albumen is prepared early period using spinner cultivation.When due to Spinner culture, body is cultivated Product is the 1/2 of bottle body product, but bottle cap stuffiness again, therefore the DO of cell growth process is compared with Customers ' Legal Right, so as to cause imitating The low phenomenon of valence;On the other hand, Spinner bottles are vials, and have 2 glass rotors, need when use especially careful, are easy broken Damage, and price is more expensive, in addition each Spinner equipment is only capable of accommodating 4 bottle positions, and receiving bottle position is less, and amplification need to purchase again Equipment, amplification are difficult.
Summary of the invention
The purpose of the present invention is to provide a kind of methods of culture insect cell preparation and reorganization TPO albumen that suspends, and prepare TPO protein biological activity it is high, be applied in thyroid peroxidase antibody detection kit, kit can be greatly improved Sensitivity, accuracy and stability.
To achieve the above object, the present invention can take following technical proposals:
The method of the present invention for suspending culture insect cell preparation and reorganization TPO albumen includes the following steps:
Recombinant baculovirus is conventionally transfected in logarithmic phase insect cell, supernatant is taken after 96h by the first step, P0 is harvested for recombinant baculovirus liquid;
Second step, primary recombinant baculovirus cell is after static gas wave refrigerator is recovered, through secondary culture, to pass on inoculating cell density ≥3-5In 10^5 inoculum concentration access triangular flasks, until cell density grows to 2-3At 10^6, passed on again Culture, until cell is in logarithmic phase, density reaches 2It is that 0.1-0.5 carries out connecing malicious P0 generation virus with MOI when 10^6cells/mL Liquid harvests cell culture supernatant, collects supernatant after centrifugal treating after 3-5 days, be virus liquid P1 generation, masking foil package after 4 DEG C It is kept in dark place;
Third step repeats the second one step process, and P2 is made for virus liquid;
4th step continues to pass on, and when cell is in logarithmic phase, density reaches 2It is 1-5 progress with MOI when 10^6cells/mL Malicious P2 is met for virus liquid, cell culture supernatant is harvested after 3-5 days, collects supernatant after centrifugal treating, is virus liquid P3 generation, potency After detection, recombination TPO albumen is obtained.
The condition of secondary culture is 27 DEG C of temperature in the second step, shaking speed 100rpm/min.
The condition of centrifugal treating is revolving speed 1500rpm/min, time 3-5 minute in the second step, the 4th step.
The advantage of the invention is that antigenic structure and native protein are more using the antigen that baculovirus insect cell is expressed It is close, and without being denaturalized purifying, the activity of antigen is preferably;It is special that recombinant baculovirus P1-P3 generation disease is carried out using shaking table culture The preparation and amplification of venom, virus titer prepare virus liquid compared with static gas wave refrigerator and promote 10 times, the antigen effect of triangular flask culture preparation Valence promotes 5 times compared with the antigen with spinner culture preparation, and is more conducive to amplify.Testing inspection, the method for the present invention preparation resist Former specificity is good, and high sensitivity and potency height are used for thyroid peroxidase antibody detection kit, can greatly improve reagent Sensitivity, accuracy and the stability of box.
Detailed description of the invention
Fig. 1 is that the antigen of the method for the present invention preparation is compared with antigen clinic coincidence rate is compareed.
Specific embodiment
More detailed explanation is made to the method for the present invention below, the understanding in order to those skilled in the art to the application. Unless otherwise specified, reagent used in the method for the present invention and equipment are commercial product, and the method used is also normal for the industry Advise the method used.
Embodiment 1 recombinates the preparation of TPO albumen (antigen)
The first step will recombinate bar according to the method for II kit specification of Cellfectin of work Invitrogen company production Shape virus transfection takes supernatant into logarithmic phase insect cell after 96h, harvest P0 for recombinant baculovirus liquid, concrete operations are such as Under:
1, by cell with 1-1.2x106The quantity of a cells/well spreads six orifice plates, and rear cell can cover with board bottom 85% or so overnight;
2, it prepares solution A -- plasmid/culture medium: being that 2ug recombinates Bacmid plasmid and is added to 100ul serum-free, unparalleled by quality It is mixed gently in anti-III SFM of SF900;
3, it prepares B solution-liposome/culture medium: the Cellfectin II of volume 8uL is added to 100ul serum-free, unparalleled In anti-III SFM culture medium of SF900, mix gently;
4, it prepares C solution: solution A and B solution being mixed, are incubated at room temperature 20min after mixing gently;
5, it takes out step 1 and spreads six orifice plates, abandon supernatant, it is primary with serum-free, III SFM culture medium board-washing of SF900 without double antibody, C solution is added dropwise in six orifice plates, light shake makes its mixing, 27 DEG C of culture 4h;
6, supernatant is sucked out, 1.5ml SF-900III culture medium, 27 degree of culture 4d(96h is added), whether observation fluorescence occurs: If fluorescence rate is greater than 85% or more, supernatant is collected, 1500rpm/min is centrifuged 3-5min, collects supernatant, is virus liquid P0 generation, tinfoil paper It is kept in dark place for 4 DEG C after paper bag is wrapped up in.
Second step, preparation of the P1 for virus liquid: after the recovery of primary cell static gas wave refrigerator, by secondary culture, with passage Inoculating cell density is not less than 3-5In 10^5 inoculum concentration access 250mL triangular flasks, triangular flask liquid amount is total volume 1/5(50mL), cell density grows to 2-3At 10^6, progress secondary culture, 27 DEG C of cultivation temperature, shaking speed 100rpm/min.After continuous passage 2-3 times, cell state is preferable, and survival rate is greater than 95%.It takes in logarithmic phase cell, with 8 × 10^5cells/mL is inoculated with 250mL triangular flask, and density reaches 2It is that 0.1-0.5 carries out meeting malicious P0 with MOI when 10^6cells/mL For virus liquid, cell culture supernatant is harvested after 3-5 days, and cell culture supernatant is centrifuged 3- in revolving speed 1500rpm/min 5min collects supernatant, is virus liquid P1 generation, is kept in dark place for 4 DEG C after masking foil wraps up.
Third step, preparation of the P2 for virus liquid: by primary cell after static gas wave refrigerator is recovered, by secondary culture, with It passes on inoculating cell density and is not less than 3-5In 10^5 inoculum concentration access 500mL triangular flasks, triangular flask liquid amount is overall Long-pending 1/5(100mL), cell density grows to 2-3At 10^6, progress secondary culture, 27 DEG C of cultivation temperature, shaking speed 100rpm/min.After continuous passage 2-3 times, cell state is preferable, and survival rate is greater than 95%.It takes in logarithmic phase cell, with 810 ^5cells/mL is inoculated with 250mL triangular flask, and density reaches 2It is that 0.1-0.5 carries out connecing malicious P1 generation with MOI when 10^6cells/mL Virus liquid harvests cell culture supernatant after 3-5 days, cell culture supernatant is centrifuged 3-5min in revolving speed 1500rpm/min, Supernatant is collected, is virus liquid P2 generation, is kept in dark place for 4 DEG C after masking foil wraps up.
4th step, preparation of the P3 for virus liquid: by primary cell after static gas wave refrigerator is recovered, by secondary culture, with It passes on inoculating cell density and is not less than 3-5In 10^5 inoculum concentration access 1000mL triangular flasks, triangular flask liquid amount is overall Long-pending 1/5(250mL), cell density grows to 2-3At 10^6, progress secondary culture, 27 DEG C of cultivation temperature, shaking speed 100rpm/min.After continuous passage 2-3 times, cell state is preferable, and survival rate is greater than 95%.It takes in logarithmic phase cell, with 810 ^5cells/mL is inoculated with 250mL triangular flask, and density reaches 2It is that 1-5 carries out connecing malicious P2 generation virus with MOI when 10^6cells/mL Liquid harvests cell culture supernatant after 3-5 days, cell culture supernatant is centrifuged 3-5min in revolving speed 1500rpm/min, is collected Supernatant is virus liquid P3 generation, and 4 DEG C are kept in dark place.
The P3 of harvest is carried out bioactivity for virus liquid, is concentrated with 30KD hollow fiber column, according to effect by the 5th step Valence is concentrated 2-5 times, and 0.22 μm of bacterial filter filtering after glycerol adding, obtained recombination TPO protein-20 DEG C saves.
The application of the recombination TPO albumen of 2 embodiment 1 of embodiment preparation
By thyroid peroxidase antibody detection kit coating technique, it is coated with after being diluted according to respective concentration with compareing Antigen is coated with simultaneously, Feng Bao, drying, corresponding index test results in the following table:
1, bioactivity: detecting the potency of antigen prepared by the present invention, after being diluted according to different concentration gradients, and compares Envelope antigen is coated with simultaneously, Feng Bao, drying, and antigen valence prepared by the present invention is promoted to compared with promoting 5 times producing antigen by 1/50 1/250, it meets the requirements.
2, sensitivity: 10 holes are measured in parallel the luminous value of B0 internal control product, calculate the average (`X) and standard of measurement result Poor (SD) calculates sensitivity with (`X ± 2SD), and testing result should be not higher than 2IU/ml, and the present invention prepares the sensitivity of antigen There is promotion compared in production antigen, minimum detected value is promoted to 0.28IU/ml from 0.35IU/ml, meets the requirements.
3, clinical comparison: clinical sample requires randomness/gradient, 100 parts of comparison or more, with control batch yin-yang value base This is consistent, as shown in Figure 1, clinical coincidence rate R2Reach 0.9952, meets the requirements.
4, general internal control product measured value: multiple holes measure Q1, Q2 internal control product, calculate measurement concentration, measurement knot with qualified S1-S6 Fruit within the allowable range, meets the requirements.
5, stability: coating plate is placed 10 days through 37 DEG C, and clinical sample detects the luminous value range of decrease and is not higher than 10%.The present invention Compared with antigen is being produced, the luminous value range of decrease is reduced to 3% by 7%, is below 10%, meets the requirements the antigen of preparation.

Claims (3)

1. a kind of method for the culture insect cell preparation and reorganization TPO albumen that suspends, it is characterised in that: include the following steps:
Recombinant baculovirus is conventionally transfected in logarithmic phase insect cell, supernatant is taken after 96h by the first step, P0 is harvested for recombinant baculovirus liquid;
Second step, primary recombinant baculovirus cell are close to pass on inoculating cell through secondary culture after static gas wave refrigerator is recovered In degree >=3-5 × 10^5 inoculum concentration access triangular flasks, until being carried out again when cell density grows to 2-3 × 10^6 Secondary culture, until cell is in logarithmic phase, it is that 0.1-0.5 carries out meeting malicious P0 with MOI when density reaches 2 × 10^6cells/mL For virus liquid, cell culture supernatant is harvested after 3-5 days, collects supernatant after centrifugal treating, be virus liquid P1 generation, masking foil package It is kept in dark place for 4 DEG C afterwards;
Third step repeats the second one step process, and P2 is made for virus liquid;
4th step continues to pass on, and is 1-5 progress with MOI when density reaches 2 × 10^6cells/mL when cell is in logarithmic phase Malicious P2 is met for virus liquid, cell culture supernatant is harvested after 3-5 days, collects supernatant after centrifugal treating, is virus liquid P3 generation, potency After detection, recombination TPO albumen is obtained.
2. the method for the culture insect cell preparation and reorganization TPO albumen according to claim 1 that suspends, it is characterised in that: institute The condition for stating secondary culture in second step is 27 DEG C of temperature, shaking speed 100rpm/min.
3. the method for the culture insect cell preparation and reorganization TPO albumen according to claim 1 that suspends, it is characterised in that: institute State second step, the condition of centrifugal treating is revolving speed 1500rpm/min, time 3-5 minute in the 4th step.
CN201811031155.6A 2018-09-05 2018-09-05 Suspend the method for cultivating insect cell preparation and reorganization TPO albumen Pending CN109022382A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811031155.6A CN109022382A (en) 2018-09-05 2018-09-05 Suspend the method for cultivating insect cell preparation and reorganization TPO albumen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811031155.6A CN109022382A (en) 2018-09-05 2018-09-05 Suspend the method for cultivating insect cell preparation and reorganization TPO albumen

Publications (1)

Publication Number Publication Date
CN109022382A true CN109022382A (en) 2018-12-18

Family

ID=64623477

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811031155.6A Pending CN109022382A (en) 2018-09-05 2018-09-05 Suspend the method for cultivating insect cell preparation and reorganization TPO albumen

Country Status (1)

Country Link
CN (1) CN109022382A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114196643A (en) * 2021-12-24 2022-03-18 中元汇吉生物技术股份有限公司 Process and method for purifying TPO

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073620A2 (en) * 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CN105861458A (en) * 2016-04-20 2016-08-17 南阳师范学院 Thyroid peroxidase expression method
CN106282131A (en) * 2016-09-30 2017-01-04 广东温氏大华农生物科技有限公司 A kind of keratinase expression system and its preparation method and application
CN107841491A (en) * 2017-11-03 2018-03-27 南阳师范学院 A kind of expression for increasing thyroid peroxidase expression quantity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073620A2 (en) * 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CN105861458A (en) * 2016-04-20 2016-08-17 南阳师范学院 Thyroid peroxidase expression method
CN106282131A (en) * 2016-09-30 2017-01-04 广东温氏大华农生物科技有限公司 A kind of keratinase expression system and its preparation method and application
CN107841491A (en) * 2017-11-03 2018-03-27 南阳师范学院 A kind of expression for increasing thyroid peroxidase expression quantity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
YING LOU ET AL.: ""Secretory expression and scale-up production of recombinant human thyroid peroxidase via baculovirus/insect cell system in a wave-type bioreactor"", 《PROTEIN EXPRESSION AND PURIFICATION》 *
刘金泉等: "hTPO膜外区基因的克隆及其杆状病毒表达载体的构建", 《天津医药》 *
娄颖: ""重组人源甲状腺过氧化物酶的分泌表达及扩大培养"", 《中国优秀硕士学位论文全文数据库 基础科学辑》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114196643A (en) * 2021-12-24 2022-03-18 中元汇吉生物技术股份有限公司 Process and method for purifying TPO

Similar Documents

Publication Publication Date Title
CN103951831B (en) The preparation method and applications of sericin hydrogel
CN107184968A (en) A kind of A types Sai Nika paddy virus sample particle vaccines and its production and use
CN104721817B (en) A kind of vaccine combination and its preparation method and application
KR20070060049A (en) Process for the production of an influenza vaccine
CN108578771B (en) Preparation method and products thereof with the FGF1 sericin gel for promoting cell-proliferation activity
CN107418936A (en) Cell factory prepares measles virus stoste and measles series attenuated live vaccine preparation
CN105861458A (en) Thyroid peroxidase expression method
DK152138B (en) PROCEDURE FOR PREPARING UROKINASE
CN109402062A (en) Application of the ZIP1 gene in the product that preparation inhibits apoptosis of mesenchymal stem cell
CN109022382A (en) Suspend the method for cultivating insect cell preparation and reorganization TPO albumen
CN109706181A (en) A kind of method, immortalization pig liver sternzellen system and application constructing immortalization pig liver sternzellen system
CN105664150A (en) Newcastle disease virus, avian influenza virus and avian adenovirus triple inactivated vaccine
CN108753736A (en) Produce the method and its application of varicella virus stoste
CN111643659A (en) Rabbit hemorrhagic disease virus baculovirus vector vaccine and preparation method thereof
CN107432931B (en) A kind of method that microcarrier culture varicella virus prepares vaccine
CN101759765A (en) Method for extracorporeally preparing transfer factor against specificity of bursal disease virus of chickens
CN102743749B (en) Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor
CN107372302B (en) The animal model for having an impact large biological molecule to cellular biology of tumor is screened in vivo
CN110129272A (en) Stablize the PK-15 cell strain for expressing MAP3K8 albumen and its building and application
CN108823205A (en) A kind of HEK293T cell line construction method knocking out PLAC8 gene
CN110387351A (en) A kind of isolation and culture method of human retina Muller cell
CN110004105A (en) A kind of application of albumen in cell culture
CN105368772B (en) A kind of method of culture substrate and its application and culture dental pulp stem cell
CN101812427A (en) Method for culturing rat airway smooth muscle cells
CN112852751A (en) Preparation and quality control method of new coronavirus nucleic acid detection and quality control virus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181218